Inflammation, Genetics, and Chronic Disease: Connecting the Dots

Chronic low-grade inflammation is a persistent, dysregulated activation of inflammatory pathways in the absence of acute threat. It is the common biological substrate of most major chronic diseases.

The Genetic Inflammatory Landscape

Individual variation in inflammatory tone is substantially genetically determined:

• IL-6 and TNF-α variants influence cytokine production and systemic inflammatory tone.
• CRP gene variants affect baseline C-reactive protein levels.
• HLA region variants determine susceptibility to autoimmune and inflammatory conditions.
• NLRP3 variants affect inflammasome activation and IL-1β production.

The Microbiome as an Inflammatory Regulator

• Butyrate-producing bacteria suppress NF-κB signalling and promote regulatory T cell differentiation.
• LPS-producing gram-negative bacteria activate TLR4, driving pro-inflammatory cytokine production.
• Reduced alpha diversity is associated with elevated inflammatory biomarkers across multiple studies.

Identifying a patient's genetic inflammatory predisposition alongside their microbiome-mediated inflammatory drivers allows practitioners to stratify risk accurately and intervene at both levels.